Therefore, ANP‐HA‐GNPs are a promising new adjuvant therapy option to treat RB tumors via non‐invasive eye drops and/or for use as prophylactic agents to prevent recurrence upon the development of chemoresistance. Here, NPPA is linked to retinoblastoma.